title: Steroids and cAMP in follicles of postpartum beef cows treated with norgestomet.
abstract: To determine time of occurrence of follicular changes that may be associated with the length of the subsequent luteal phase, follicles were collected at different times before ovulation from cows expected to have corpora lutea of short (control) or normal (norgestomet-treated) life span. Beginning on d 20 to 23 postpartum (d 0 of study), 34 crossbred beef cows received either a 6-mg implant of norgestomet for 9 d or served as untreated controls. Ovaries were removed from norgestomet-treated cows on d 6 (N6; n = 9), d 8 (N8; n = 8), or the day after implant removal (N10; n = 8). Control cows were ovariectomized on d 6 (C6; n = 4) or d 10 (C10; n = 5). The largest and second largest follicles greater than 8 mm (F1 and F2, respectively) were dissected from the ovaries. Granulosal and thecal layers and follicular fluid were separated and assayed for estradiol-17 beta, progesterone, androstenedione, and testosterone. Cyclic 3'5'adenosine monophosphate (cAMP) was determined in thecal and granulosal tissue. Diameters of the F1 (14.6 +/- .4 mm) and F2 (10.6 +/- .4 mm) did not differ due to treatment. A greater proportion (P less than .05) of the F1 (20/33) than of the F2 (4/27) had estradiol:progesterone ratios of greater than 1 in follicular fluid. Contents of estradiol, androstenedione, and testosterone in theca and granulosa and follicular fluid, androstenedione in theca, and testosterone in theca and follicular fluid (all P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: West Virginia University, Morgantown 26506.
authors.forename: S K
authors.initials: SK
authors.lastname: Johnson
authors.forename: P E
authors.initials: PE
authors.lastname: Lewis
authors.forename: E K
authors.initials: EK
authors.lastname: Inskeep
mesh_terms: D000735:Androstenedione / Q000032:analysis; D000818:Animals; D002417:Cattle / Q000502:physiology*; D000242:Cyclic AMP / Q000032:analysis*; D004958:Estradiol / Q000032:analysis; D005260:Female; D012739:Gonadal Steroid Hormones / Q000032:analysis*; D008183:Luteal Phase; D006080:Ovarian Follicle / Q000737:chemistry* / Q000187:drug effects / Q000502:physiology; D049590:Postpartum Period / Q000187:drug effects / Q000502:physiology; D011282:Pregnenediones / Q000494:pharmacology*; D011374:Progesterone / Q000032:analysis; D045167:Progesterone Congeners / Q000494:pharmacology; D013739:Testosterone / Q000032:analysis
chemical_list: D012739:Gonadal Steroid Hormones; D011282:Pregnenediones; D045167:Progesterone Congeners; C100284:norgestomet; D013739:Testosterone; D000735:Androstenedione; D011374:Progesterone; D004958:Estradiol; D000242:Cyclic AMP